Predictive Value of a Thyroid-Absorbed Dose with a Shorter Effective Half-Life on Efficacy in Graves Disease Patients Receiving Iodine-131 Therapy

Feng Yu; Ruiguo Zhang; Guizhi Zhang; Zhaowei Meng; Xiaohua Liu; Yajing He; Jian Tan; Renfei Wang

doi:10.12659/MSM.928796

26 January 2021 : Clinical Research

Predictive Value of a Thyroid-Absorbed Dose with a Shorter Effective Half-Life on Efficacy in Graves Disease Patients Receiving Iodine-131 Therapy

Feng Yu^1BCEF, Ruiguo Zhang^1CDF, Guizhi Zhang^1B, Zhaowei Meng^1B, Xiaohua Liu^1B, Yajing He^1B, Jian Tan^1D, Renfei Wang^1ADG*

DOI: 10.12659/MSM.928796

Med Sci Monit 2021; 27:e928796

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 The distribution of efficacy for Graves disease patients between the 2 groups with effective half-life (Teff) ≤3 d and Teff of >3 to ≤5 days.

Back to the Article

Predictive Value of a Thyroid-Absorbed Dose with a Shorter Effective Half-Life on Efficacy in Graves Disease Patients Receiving Iodine-131 Therapy

Your Privacy